VWF and acquired von willebrand syndrome: First, the high shear forces and continuous flow of the Impella lead to the proteolysis of the high-molecular-weight von Willebrand factor, reducing platelet-binding affinity and causing acquired von Willebrand syndrome in a majority of patients within 24 h of initiating Impella use [26, 27].